BOEHRINGER INGELHEIM VENTURE FUND
Boehringer Ingelheim Venture Fund GmbH (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research. BIVF is searching for significant enhancements in patient care through pioneering science and its clinical translation by building long-term relationships with scientists and entrepreneurs. BIVF’s focus is to target unprecedented therapeutic concepts addressing high medical needs in immuno-oncology, regenerative medicine, infectious diseases and digital health. These may include novel platform technologies to address so far undruggable targets, new generation vaccines and/or new biological entities, such as oncolytic virotherapy.
BOEHRINGER INGELHEIM VENTURE FUND
Industry:
Biotechnology Finance Venture Capital
Founded:
2010-01-01
Status:
Active
Contact:
+49 6132 77 90780
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Apache ReCAPTCHA New Relic GlobalSign GlobalSign Domain Verification
Similar Organizations
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
Novartis Venture Fund
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Employees Featured
Frank Kalkbrenner Director, Investment Manager @ Boehringer Ingelheim Venture Fund
Director, Investment Manager
2010-07-01
Kanad Das Investment Director, Boehringer Ingelheim Venture Fund @ Boehringer Ingelheim Venture Fund
Investment Director, Boehringer Ingelheim Venture Fund
Knut Elbers Project Manager @ Boehringer Ingelheim Venture Fund
Project Manager
Debbie W. Lin Executive Director @ Boehringer Ingelheim Venture Fund
Executive Director
Oliver Reuss Executive Director and Investment Manager @ Boehringer Ingelheim Venture Fund
Executive Director and Investment Manager
Martin Heidecker Managing Director @ Boehringer Ingelheim Venture Fund
Managing Director
2013-10-01
Ilka Wicke Head Making more Health @ Boehringer Ingelheim Venture Fund
Head Making more Health
2020-11-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-01 | C-mo Medical Solutions | Boehringer Ingelheim Venture Fund investment in Seed Round - C-mo Medical Solutions | 4.1 M EUR |
| 2022-06-13 | ImCheck Therapeutics | Boehringer Ingelheim Venture Fund investment in Series C - ImCheck Therapeutics | 96 M EUR |
| 2022-03-03 | ArrePath | Boehringer Ingelheim Venture Fund investment in Seed Round - ArrePath | 20 M USD |
| 2022-02-16 | Centauri Therapeutics | Boehringer Ingelheim Venture Fund investment in Series A - Centauri Therapeutics | 24 M GBP |
| 2021-12-16 | Brainomix | Boehringer Ingelheim Venture Fund investment in Series B - Brainomix | 16 M GBP |
| 2021-12-09 | OncoMyx Therapeutics | Boehringer Ingelheim Venture Fund investment in Series B - OncoMyx Therapeutics | 50 M USD |
| 2021-12-08 | Viron Inc. | Boehringer Ingelheim Venture Fund investment in Series B - Viron Inc. | 50 M USD |
| 2021-11-09 | Asgard Therapeutics | Boehringer Ingelheim Venture Fund investment in Seed Round - Asgard Therapeutics | 6 M EUR |
| 2021-10-28 | Optina Diagnostics | Boehringer Ingelheim Venture Fund investment in Series A - Optina Diagnostics | 24.8 M CAD |
| 2021-10-14 | Abalos Therapeutics | Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics | 31 M EUR |
More informations about "Boehringer Ingelheim Venture Fund"
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund (BIVF) acquires minority stakes in biotech start-ups exploring promising therapies and technologies, and even supports the majority before and during their founding. ... Our experienced … See details»
Boehringer Ingelheim Venture Fund - Crunchbase
Boehringer Ingelheim Venture Fund GmbH (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research. BIVF is searching for … See details»
Boehringer Ingelheim Venture Fund - F6S
The Boehringer Ingelheim Venture Fund has an initial commitment of €300 million. Opening investments of up to €3 million per venture will be made at the early stage with subsequent … See details»
Boehringer Ingelheim Venture Fund | Institution Profile | Private ...
Boehringer Ingelheim Venture Fund News, insights, analysis and data Founded in 2010, Boehringer Ingelheim Venture Fund is a German-based organisation that specialises in early-stage … See details»
Boehringer Ingelheim launches Global Venture Fund to foster …
Apr 6, 2010 Innovators interested in contacting the BI Venture Fund, please visit: www.boehringer-ingelheim-venture.com. About Boehringer Ingelheim The Boehringer Ingelheim group is one of … See details»
Boehringer Ingelheim Venture Fund invests precision antimicrobials ...
The joint investment by Boehringer Ingelheim Venture Fund, Qbic and Gemma Frisius Fund amounts to 4 million EUR. Recently Boehringer Ingelheim Venture Fund also invested jointly with Scottish … See details»
About us - Boehringer Ingelheim Venture Fund
Established in 2010, the Boehringer Ingelheim Venture Fund (BIVF) is a €350M evergreen fund with a global presence in the EU, US, and China. BIVF is committed to advancing scientific innovation … See details»
Boehringer Ingelheim Venture Fund | Boehringer …
Dabei helfen ihnen unsere erfahrenen Mitarbeitenden des Venture Funds, die in der Regel aus der Boehringer Ingelheim F&E Organisation rekrutiert wurden“, sagt Kalkbrenner. „Wir unterstützen außerdem bei Lizenzverhandlungen mit … See details»
BIVF funding more than doubled to 250 M€
Jan 3, 2018 Ingelheim, Germany and Boston, MA, USA – 3 January, 2018 - Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from … See details»
Reigniting Biopharma’s Research Engine | BCG
1 day ago BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of … See details»
Boehringer Ingelheim Venture Fund USA Inc. (BIVF USA)
Aug 7, 2021 Created in 2010, the Boehringer Ingelheim Venture Fund (BIVF) invests in ground-breaking therapeutics-focused biotechnology companies to drive innovation in biomedical … See details»
Our Team - Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund. Boehringer Ingelheim Venture Fund. Our team. Filter by team. Filter by Job title Reset all filters Manuel Baader ... See details»
Our portfolio - Boehringer Ingelheim Venture Fund
Since its inception in 2010, the Boehringer Ingelheim Venture Fund has invested in over 70 companies (incl. 7 fund-in-fund investments). Currently, the active portfolio comprises more than … See details»
Boehringer Ingelheim Showcases Bold Vision for the Future of …
May 22, 2025 Boehringer Ingelheim will present the latest data in its robust oncology pipeline at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including patient-reported … See details»
Carlos Alvarez - Manager - Boehringer Ingelheim | LinkedIn
Manager at Boehringer Ingelheim · Experience: Boehringer Ingelheim · Location: Woodbridge · 18 connections on LinkedIn. View Carlos Alvarez’s profile on LinkedIn, a professional community of ... See details»
Fei Shen | Boehringer Ingelheim Venture Fund
During the 13-year she spent in the R&D organizations, Fei and her team have contributed to two approved products and many assets in the clinical pipeline ranging from Ph1 to Ph3. In 2020, she … See details»
Boehringer Ingelheim Showcases Bold Vision for the Future of …
May 22, 2025 About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and … See details»
Contact - Boehringer Ingelheim Venture Fund
The designated contact mailbox is reviewed weekly. Please note: Communications pertaining to business development, recruitment services, consultancy, deal advisory, legal and intellectual … See details»
Black Opportunity Fund launches investment firm to support Black ...
2 days ago Raising $150-million will represent only one-tenth of the $1.5-billion 10-year fundraising target the Black Opportunity Fund set when it was first established in 2020, though Mr. Wellington … See details»
Susan Stamos - Global Submission Specialist - Boehringer Ingelheim ...
Global Submission Specialst at Boehringer Ingelheim · Global Regulatory Operations professional in the biopharma industry with over 32 years project management and eCTD experience using ... See details»